Physician

Usman Javed, MD

According to 2025 Medicare claims, Usman Javed, MD (NPI: 1770592578) practices cardiology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is COMMUNITY FOUNDATION MEDICAL GROUP (NPI: 1811258510; TIN: 270271872) and primary practice location at 93720-3306.

Javed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,873 traditional Medicare patients, billed 15,090 HCPCS/CPT codes, and received $1,805,816 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 18,181 prescription claims across 2,408 beneficiaries totaling $4,171,734 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 18 claims. Open Payments data shows 25 records totaling $1,752. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $656,494 to $1,805,816. Similarly, Part D prescription costs have moved sharply higher in recent years, from $166,913 to $4,171,734. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $38,751 to $4,631.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,745	5,037	$656,494
2016	1,774	5,643	$598,379
2017	1,886	6,337	$707,800
2018	1,675	6,417	$789,379
2019	2,151	8,647	$1,432,950
2020	2,323	9,699	$1,565,972
2021	2,266	10,302	$1,693,278
2022	2,037	10,694	$1,508,967
2023	2,520	12,169	$1,641,599
2024	2,873	15,090	$1,805,816

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	394	4,373	$166,913
2016	522	6,230	$309,669
2017	646	8,104	$540,465
2018	704	6,851	$640,627
2019	767	7,697	$724,853
2020	964	9,051	$1,178,161
2021	1,241	10,462	$1,525,798
2022	1,483	10,892	$1,819,191
2023	1,843	12,846	$2,804,871
2024	2,408	18,181	$4,171,734

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	19	$38,751
2019	N/R	19	$38,645
2020	N/R	12	$27,173
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	31	$1,554
2024	N/R	18	$1,216

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,028	1,075	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,287	1,790	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,377	2,212	$68
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,428	1,635	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	493	563	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	732	46,937	$966,268
Eliquis	Apixaban	772	50,606	$965,279
Farxiga	Dapagliflozin Propanediol	585	36,184	$643,510
Repatha Sureclick	Evolocumab	774	31,561	$597,910
Xarelto	Rivaroxaban	120	9,240	$168,848

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,216

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$1,752	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Usman Javed, MD?

Tedicare shows public-source Medicare data for Usman Javed, MD (NPI 1770592578), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Usman Javed, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Usman Javed, MD?

Usman Javed, MD is linked to COMMUNITY FOUNDATION MEDICAL GROUP (billing NPI 1811258510) in the available physician profile data.

Does Usman Javed, MD have Open Payments data?

Usman Javed, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.